Author:
Carbonell-Estrany X.,Bont L.,Doering G.,Gouyon J-B.,Lanari M.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference60 articles.
1. Horn SD, Smout RJ (2003) Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. J Pediatr 143:S133–S141
2. Willson DF, Landrigan CP, Horn SD, Smouht RJ (2003) Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr 143(Suppl 1):S142–S149
3. Boyce TG, Mellen BG, Mitchel EF et al (2000) Rates of hospitalisation for respiratory syncytial virus infection among children in Medicaid. J Pediatr 137:865–870
4. Imaizumi S, Agarwal S, Pereira G (2001) Severity of respiratory syncytial virus (RSV) infection in hospitalized premature infants: the effect of gestational age and immune prophylaxis with palivizumab. APS/SPR/APA Annual Meeting, Baltimore, MD
5. IMpact-RSV Study Group (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalisation from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531–537
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献